UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

_______________________

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

_______________________

 

 

Date of Report

 

(Date of earliest

event reported):            November 7, 2017

 

 

  National Research Corporation    
  (Exact name of registrant as specified in its charter)    
       

   Wisconsin    

0-29466

 

47-0634000

(State or other

jurisdiction of

incorporation)

(Commission File

Number)

 

(IRS Employer

Identification No.)

 

1245 Q Street, Lincoln, Nebraska 68508

(Address of principal executive offices, including zip code)

 

(402) 475-2525

(Registrant ’s telephone number)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company □

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

 

 
 

 

Item 2.02 .

Results of Operations and Financial Condition .

 

On November 7, 2017, National Research Corporation (the “Company”) issued a press release announcing its earnings for the quarter ended September 30, 2017. A copy of such press release is furnished as Exhibit 99.1 and is incorporated by reference herein.

 

On November 8, 2017, the Company held a conference call and online Web simulcast in connection with the Company’s announcement of its earnings for the quarter ended September 30, 2017. A copy of the script for such conference call and simulcast is furnished as Exhibit 99.2 and is incorporated by reference herein. An archive of such conference call and simulcast and the related question and answer session will be available online at http s ://edge.media-server.com/m 6 /p/ jfk3domr .

 

Item  9.01 .

Financial Statements and Exhibits .

 

  (a) Not applicable.
     
  (b) Not applicable.
     
  (c) Not applicable.
     
  (d ) Exhibits . The exhibits listed in the exhibit index below are being furnished herewith.

 

 

 

EXHIBIT INDEX

 

 

(99.1)

Press Release of National Research Corporation, dated November 7, 2017.

 

 

(99.2)

Script for conference call and online Web simulcast, held November 8, 2017.

 

-2-
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 8, 2017

 

 

NATIONAL RESEARCH CORPORATION

 

     

 

 

 

 

 

 

 

 

 

By:

/s/  Kevin R. Karas

 

 

 

Kevin R. Karas

 

 

 

Senior Vice President Finance, Chief Financial

Officer, Treasurer and Secretary

 

 

-3-

National Research Corp. (delisted) (NASDAQ:NRCIB)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more National Research Corp. (delisted) Charts.
National Research Corp. (delisted) (NASDAQ:NRCIB)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more National Research Corp. (delisted) Charts.